Search Results 1261-1270 of 19432 for Hemoglobin

1. Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET - Mayo Clinic

   * Hemoglobin (Hb) ≥ 8 g/dL * Creatinine clearance \> 40 mL/min calculated by the Cockcroft Gault method * Total bilirubin ≤ 3 x ULN * Potassium within ...

2. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... hemoglobin ≥ 8 g/dL. Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator. Initial ...

3. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Hemoglobin > 8.0 g/dl. Must have an apheresis product of non-mobilized cells accepted for manufacturing; Women of child-bearing potential (defined as all ...

4. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; Creatinine ≤ 2 x upper limits of normal (ULN); Bilirubin ≤ 1.5 x ULN; Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ...

5. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   No hemoglobin decrease greater than 2.0 g/dL or an unexplained rising C-reactive protein (CRP), greater than 5.0 mg/L to a concentration above the ...

6. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

   Hemoglobin concentration <9 g/dL at screening; Hepatic dysfunction as defined by Child-Pugh Class B or C. Participating Mayo Clinic locations. Study statuses ...

7. Prescription of Letrozole for Uterine Myoma - Mayo Clinic

   * Screening serum hemoglobin \<8 g/dL, or history of blood transfusion in the last 12 weeks (indicating severe anemia) * Screening cholesterol lipid panel ...

8. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL;; ANC ≥ 1.5 x 10^9/L;; Platelet count ≥ 75 x 10^9/L. Serum creatinine ≥ ULN; or estimated creatinine clearance ≥ 50 mL/min by ...

9. Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients with Resected Pancreatic Cancer (the "Apact" Study) - Mayo Clinic

   Hemoglobin (Hgb) ≥9 g/dL. Acceptable blood chemistry levels: Aspartate aminotransferase (AST)/ Serum glutamic oxaloacetic transaminase (SGOT) and Alanine ...

10. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

    Hemoglobin (HgB) ≥ 9.0 gm/dL; Alkaline phosphatase ≤ 2.5 x ULN; Creatinine clearance > 50 ml/min, by either Cockcroft-Gault formula or 24-hour urine ...